Targeted and Random Mutagenesis of for the Identification of Genes Required for Infection

English version České info

Ehrlichia chaffeensis is a tick transmitted pathogen responsible for the disease human monocytic ehrlichiosis. Research to elucidate gene function in rickettsial pathogens is limited by the lack of genetic manipulation methods. Mutational analysis was performed, targeting to specific and random insertion sites within the bacterium's genome. Targeted mutagenesis at six genomic locations by homologous recombination and mobile group II intron-based methods led to the consistent identification of mutants in two genes and in one intergenic site; the mutants persisted in culture for 8 days. Three independent experiments using Himar1 transposon mutagenesis of E. chaffeensis resulted in the identification of multiple mutants; these mutants grew continuously in macrophage and tick cell lines. Nine mutations were confirmed by sequence analysis. Six insertions were located within non-coding regions and three were present in the coding regions of three transcriptionally active genes. The intragenic mutations prevented transcription of all three genes. Transposon mutants containing a pool of five different insertions were assessed for their ability to infect deer and subsequent acquisition by Amblyomma americanum ticks, the natural reservoir and vector, respectively. Three of the five mutants with insertions into non-coding regions grew well in deer. Transposition into a differentially expressed hypothetical gene, Ech_0379, and at 18 nucleotides downstream to Ech_0230 gene coding sequence resulted in the inhibition of growth in deer, which is further evidenced by their failed acquisition by ticks. Similarly, a mutation into the coding region of ECH_0660 gene inhibited the in vivo growth in deer. This is the first study evaluating targeted and random mutagenesis in E. chaffeensis, and the first to report the generation of stable mutants in this obligate intracellular bacterium. We further demonstrate that in vitro mutagenesis coupled with in vivo infection assessment is a successful strategy in identifying genomic regions required for the pathogen's in vivo growth.

Vyšlo v časopise: Targeted and Random Mutagenesis of for the Identification of Genes Required for Infection. PLoS Pathog 9(2): e32767. doi:10.1371/journal.ppat.1003171
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003171

Souhrn

Zdroje

1. GayleA, RingdahlE (2001) Tick-borne diseases. Am Fam Physician 64: 461–466.

2. PaddockCD, ChildsJE (2003) Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 16: 37–64.

3. ParolaP, RaoultD (2001) Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32: 897–928.

4. DawsonJE (1996) Human ehrlichiosis in the United States. Curr Clin Top Infect Dis 16: 164–171.

5. DawsonJE, EwingSA (1992) Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am J Vet Res 53: 1322–1327.

6. DumlerJS, BakkenJS (1995) Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 20: 1102–1110.

7. AndersonBE, DawsonJE, JonesDC, WilsonKH (1991) Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 29: 2838–2842.

8. WalkerDH, PaddockCD, DumlerJS (2008) Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections. Med Clin North Am 92: 1345–1361.

9. WalkerDH, DumlerJS (1996) Emergence of the ehrlichiosis as human health problems. Emerg Infect Dis 2: 18–29.

10. DumlerJS, MadiganJE, PusterlaN, BakkenJS (2007) Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 45 Suppl 1: S45–S51.

11. OteoJA, BrouquiP (2005) [Ehrlichiosis and human anaplasmosis.]. Enferm Infecc Microbiol Clin 23: 375–380.

12. RikihisaY (1991) The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 4: 286–308.

13. AndrewHR, NorvalRA (1989) The carrier status of sheep, cattle and African buffalo recovered from heartwater. Vet Parasitol 34: 261–266.

14. DumlerJS, SutkerWL, WalkerDH (1993) Persistent Infection with Ehrlichia chaffeensis. Clin Infect Dis 17: 903–905.

15. SeoGM, ChengC, TomichJ, GantaRR (2008) Total, membrane, and immunogenic proteomes of macrophage- and tick cell-derived Ehrlichia chaffeensis evaluated by LC-MS/MS and MALDI-TOF methods. Infect Immun 76: 4823–4832 (PMID: 18710870).

16. SinguV, LiuH, ChengC, GantaRR (2005) Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. Infect Immun 73: 79–87.

17. SinguV, PeddireddiL, SirigireddyKR, ChengC, MunderlohUG, et al. (2006) Unique Macrophage and Tick Cell-specific Protein Expression from the p28/p30 Omp Multigene Locus in Ehrlichia Species. Cell Microbiol 8: 1475–1487.

18. GantaRR, PeddireddiL, SeoGM, DedonderSE, ChengC, et al. (2009) Molecular characterization of Ehrlichia interactions with tick cells and macrophages. Front Biosci 14: 3259–3273 (PMID: 19273271).

19. GantaRR, ChengC, MillerEC, McGuireBL, PeddireddiL, et al. (2007) Differential clearance and immune responses to tick cell-derived versus macrophage culture-derived Ehrlichia chaffeensis in mice. Infect Immun 75: 135–145 (PMID: 17060466).

20. LiJS, WinslowGM (2003) Survival, Replication, and Antibody Susceptibility of Ehrlichia chaffeensis outside of Host Cells. Infect Immun 71: 4229–4237.

21. LiuT, ShiY, LiuX-f, GuoY, MaoX-h, et al. (2012) Helicobacter pylori HP0876 is Dispensable for Heme–Iron Acquisition but Attenuates Bacterial Adherence to Gastric Epithelial Cells. Current Microbiology 1–8.

22. YevsaT, EbensenT, FuchsB, ZygmuntB, LibanovaR, et al. (2012) Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology. Environmental Microbiology 15: 64–76.

23. DriskellLO, YuX-j, ZhangL, LiuY, PopovVL, et al. (2009) Directed Mutagenesis of the Rickettsia prowazekii pld Gene Encoding Phospholipase D. Infection and Immunity 77: 3244–3248.

24. RachekLI, TuckerAM, WinklerHH, WoodDO (1998) Transformation of Rickettsia prowazekii to rifampin resistance. J Bacteriol 180: 2118–2124.

25. LambowitzAM, ZimmerlyS (2011) Group II Introns: Mobile Ribozymes that Invade DNA. Cold Spring Harbor Perspectives in Biology 3.

26. CuiX, DavisG (2007) Mobile group II intron targeting: applications in prokaryotes and perspectives in eukaryotes. Front Biosci 12: 4972–4985.

27. KarbergM, GuoH, ZhongJ, CoonR, PerutkaJ, et al. (2001) Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat Biotech 19: 1162–1167.

28. FrazierCL, San FilippoJ, LambowitzAM, MillsDA (2003) Genetic Manipulation of Lactococcus lactis by Using Targeted Group II Introns: Generation of Stable Insertions without Selection. Applied and Environmental Microbiology 69: 1121–1128.

29. PerutkaJ, WangW, GoerlitzD, LambowitzAM (2004) Use of Computer-designed Group II Introns to Disrupt Escherichia coli DExH/D-box Protein and DNA Helicase Genes. Journal of Molecular Biology 336: 421–439.

30. YaoJ, ZhongJ, FangY, GeisingerE, NovickRP, et al. (2006) Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. Rna 12: 1271–1281.

31. ChenY, McClaneBA, FisherDJ, RoodJI, GuptaP (2005) Construction of an Alpha Toxin Gene Knockout Mutant of Clostridium perfringens Type A by Use of a Mobile Group II Intron. Applied and Environmental Microbiology 71: 7542–7547.

32. FelsheimRF, HerronMJ, NelsonCM, BurkhardtNY, BarbetAF, et al. (2006) Transformation of Anaplasma phagocytophilum. BMC Biotechnol 6: 42.

33. AkerleyBJ, RubinEJ, CamilliA, LampeDJ, RobertsonHM, et al. (1998) Systematic identification of essential genes by in vitro mariner mutagenesis. Proc Natl Acad Sci U S A 95: 8927–8932.

34. BearePA, GilkSD, LarsonCL, HillJ, SteadCM, et al. (2011) Dot/Icm Type IVB Secretion System Requirements for Coxiella burnetii Growth in Human Macrophages. mBio 2: 175.

35. BearePA, HoweD, CockrellDC, OmslandA, HansenB, et al. (2009) Characterization of a Coxiella burnetii ftsZ mutant generated by Himar1 transposon mutagenesis. J Bacteriol 191: 1369–1381.

36. CartmanST, MintonNP (2010) A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl Environ Microbiol 76: 1103–1109.

37. LiuZM, TuckerAM, DriskellLO, WoodDO (2007) Mariner-based transposon mutagenesis of Rickettsia prowazekii. Appl Environ Microbiol 73: 6644–6649.

38. Le BretonY, MohapatraNP, HaldenwangWG (2006) In vivo random mutagenesis of Bacillus subtilis by use of TnYLB-1, a mariner-based transposon. Appl Environ Microbiol 72: 327–333.

39. JonesAL, KnollKM, RubensCE (2000) Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol 37: 1444–1455.

40. HudsonP, GortonTS, PapazisiL, CecchiniK, FrascaSJr, et al. (2006) Identification of a virulence-associated determinant, dihydrolipoamide dehydrogenase (lpd), in Mycoplasma gallisepticum through in vivo screening of transposon mutants. Infect Immun 74: 931–939.

41. HimpslSD, LockatellCV, HebelJR, JohnsonDE, MobleyHL (2008) Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol 57: 1068–1078.

42. HotoppJC, LinM, MadupuR, CrabtreeJ, AngiuoliSV, et al. (2006) Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2: e21.

43. Cheng C, Gong S, Ganta RR (2010) Evaluation of Methods for Establishing Mutations in Ehrlichia chaffeensis by Homologous Recombination and Targetron Based Mutagenesis [Abstract #45]. In: the 24th Meeting of the American Society for Rickettsiology; July 31–August 3, 2010; Skamania Lodge, Stevenson, Washington, United States. Available: http://www.vet.k-state.edu/CE/asr/ASR_Schedule.pdf.

44. LongSW, WhitworthTJ, WalkerDH, YuXJ (2005) Overcoming barriers to the transformation of the genus Ehrlichia. Ann N Y Acad Sci 1063: 403–410.

45. LongSW, ZhangXF, QiH, StandaertS, WalkerDH, et al. (2002) Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun 70: 1824–1831.

46. UnverA, RikihisaY, StichRW, OhashiN, FelekS (2002) The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts. Infect Immun 70: 4701–4704.

47. LockhartJM, DavidsonWR, StallknechtDE, DawsonJE, LittleSE (1997) Natural history of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) in the piedmont physiographic province of Georgia. J Parasitol 83: 887–894.

48. SteiertJG, GilfoyF (2002) Infection rates of Amblyomma americanum and Dermacentor variabilis by Ehrlichia chaffeensis and Ehrlichia ewingii in southwest Missouri. Vector Borne Zoonotic Dis 2: 53–60.

49. OramDM, AvdalovicA, HolmesRK (2002) Construction and characterization of transposon insertion mutations in Corynebacterium diphtheriae that affect expression of the diphtheria toxin repressor (DtxR). J Bacteriol 184: 5723–5732.

50. WangY, KahaneS, CutcliffeLT, SkiltonRJ, LambdenPR, et al. (2011) Development of a Transformation System for Chlamydia trachomatis: Restoration of Glycogen Biosynthesis by Acquisition of a Plasmid Shuttle Vector. PLoS Pathog 7: e1002258.

51. KrulwichTA, HicksDB, ItoM (2009) Cation/proton antiporter complements of bacteria: why so large and diverse? Mol Microbiol 74: 257–260.

52. EllisonMJ, KelleherRJ, RichA (1985) Thermal regulation of beta-galactosidase synthesis using anti-sense RNA directed against the coding portion of the mRNA. Journal of Biological Chemistry 260: 9085–9087.

53. KiselevVI, TarasovaIM (1988) [Regulation of expression of the Escherichia coli htpR gene by antisense RNA]. Mol Biol 22: 454–458.

54. KiselevVI, TarasovaIM (1988) Regulation of proteolysis in Escherichia coli cells by antisense RNA of htpR gene. Biotechnol Appl Biochem 10: 59–62.

55. ChenSM, PopovVL, FengHM, WenJ, WalkerDH (1995) Cultivation of Ehrlichia chaffeensis in mouse embryo, Vero, BGM, and L929 cells and study of Ehrlichia-induced cytopathic effect and plaque formation. Infect Immun 63: 647–655.

56. MunderlohUG, JauronSD, FingerleV, LeitritzL, HayesSF, et al. (1999) Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol 37: 2518–2524.

57. ChengC, GantaRR (2008) Laboratory maintenance of Ehrlichia chaffeensis and Ehrlichia canis and recovery of organisms for molecular biology and proteomics studies. Curr Protoc Microbiol 3: 1.

58. KuriakoseJA, MiyashiroS, LuoT, ZhuB, McBrideJW (2011) Ehrlichia chaffeensis transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation. PLoS One 6: 6.

59. SirigireddyKR, GantaRR (2005) Multiplex detection of Ehrlichia and Anaplasma species pathogens in peripheral blood by real-time reverse transcriptase-polymerase chain reaction. J Mol Diagn 7: 308–316.

60. Sambrook J, Russell DW (2000) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.

61. ChunKT, EdenbergHJ, KelleyMR, GoeblMG (1997) Rapid amplification of uncharacterized transposon-tagged DNA sequences from genomic DNA. Yeast 13: 233–240.

62. PatrickCD, HairJA (1975) Ecological observations on Dermacentor albipictus (Packard) in eastern Oklahoma (Acarina: Ixodidae). J Med Entomol 12: 393–394.